SLC25A42 Activators
SLC25A42 engage in various molecular interactions that enhance its function in coenzyme A transport into the mitochondria. Resveratrol, through its activation of SIRT1, upregulates mitochondrial function, which in turn raises the demand for coenzyme A. SLC25A42 meets this demand by facilitating the increased transport of coenzyme A into the mitochondria. Similarly, pioglitazone acts on the PPARγ pathway to promote the biosynthesis of mitochondria-related phospholipids that are integral to mitochondrial membrane composition. This biosynthetic activity elevates the necessity for coenzyme A in the mitochondria, thereby functionally increasing the activity of SLC25A42. Nicotinamide mononucleotide (NMN) serves as a precursor to NAD+, a molecule vital for mitochondrial energy processes, which when supplemented, escalates the demand for mitochondrial coenzyme A, enhancing SLC25A42 activity to support this increased demand.
SLC25A42 activity by affecting mitochondrial metabolism and energy homeostasis. Leptin, while primarily recognized for its role in energy regulation, indirectly elevates the functional demand for SLC25A42 by intensifying the need for coenzyme A during fatty acid oxidation in mitochondria. Bezafibrate and L-Carnitine, through their actions on PPARs and fatty acid transport, respectively, increase mitochondrial fatty acid β-oxidation, which subsequently requires a greater supply of coenzyme A that SLC25A42 provides. AICAR, an AMP analog, activates AMPK leading to a surge in mitochondrial biogenesis and fatty acid oxidation, which similarly promotes the activity of SLC25A42 due to the higher coenzyme A transport needs. Lastly, Coenzyme Q10, a key player in the electron transport chain and ATP synthesis, supports mitochondrial health, which could enhance SLC25A42 activity by increasing the functional demand for coenzyme A transport into the mitochondria. These chemical activators collectively enhance the activity of SLC25A42 by escalating the transport of coenzyme A, a corequisite for the proper functioning of mitochondrial metabolic pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol found in red wine, is known to activate SIRT1, which in turn has been shown to enhance mitochondrial function by deacetylating specific substrates. SLC25A42 is involved in the transport of coenzyme A into the mitochondria, which is crucial for fatty acid oxidation and the tricarboxylic acid cycle. Activation of mitochondrial function by SIRT1 could therefore increase the demand for coenzyme A transport, thereby functionally activating SLC25A42. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, enhances the biosynthesis of mitochondria-related phospholipids. SLC25A42 is implicated in mitochondrial function and its activity is closely tied to mitochondrial health and phospholipid composition. By promoting the formation of mitochondrial membranes through PPARγ activation, pioglitazone can elevate the functional demand for SLC25A42 activity as it may increase the requirement for coenzyme A transport into the mitochondria for phospholipid synthesis. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN is a precursor molecule for nicotinamide adenine dinucleotide (NAD+), which is essential for mitochondrial energy metabolism. Increasing NAD+ levels through NMN supplementation can stimulate mitochondrial biogenesis and function. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate is a fibric acid derivative used as a lipid-lowering agent that acts as an agonist for PPARs, including PPARα. Activation of PPARα leads to upregulation of genes involved in fatty acid transport and β-oxidation in mitochondria, processes that require coenzyme A. The increased metabolic flux through these pathways would necessitate heightened coenzyme A import by SLC25A42, thereby functionally activating this protein. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an analog of adenosine monophosphate (AMP) that can activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. Activation of AMPK by AICAR can lead to enhanced mitochondrial biogenesis and fatty acid oxidation. As SLC25A42 is critical for transporting coenzyme A into mitochondria, necessary for these metabolic processes, AICAR can indirectly activate SLC25A42 by increasing the functional requirement for its transport activity within the mitochondria. | ||||||
L-Carnitine | 541-15-1 | sc-205727 sc-205727A sc-205727B sc-205727C | 1 g 5 g 100 g 250 g | $23.00 $34.00 $79.00 $179.00 | 3 | |
L-Carnitine facilitates the transport of fatty acids into mitochondria for β-oxidation. Enhanced fatty acid oxidation increases the demand for acetyl-CoA production, which necessitates the presence of coenzyme A within the mitochondria. Since SLC25A42 is responsible for the import of coenzyme A into mitochondria, L-Carnitine can indirectly activate SLC25A42 by escalating the need for its activity to sustain the increased fatty acid oxidation. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin is an anti-diabetic drug that activates AMPK, which in turn stimulates mitochondrial biogenesis and enhances fatty acid oxidation. This metabolic shift increases the requirement for coenzyme A in the mitochondria, thus indirectly activating SLC25A42 by increasing the necessity for its function in coenzyme A transport to support the elevated metabolic processes. | ||||||